FDA Plans New Safety Assessment Of Dabigatran (Pradaxa)

FDA Plans New Safety Assessment Of Dabigatran (Pradaxa)

Since the approval of dabigatran (Pradaxa, Boehringer Ingelheim) in Europe in 2008 and in the US in 2010 there have been persistent and lingering concerns about the drug's safety. Now the FDA plans to perform a large new assessment of the drug 

10
Like
Save

Comments

Write a comment

*